We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAST
3701
DELISTED
Carrols Restaurant Group, Inc.
TAST
$25K ﹤0.01%
4,239
-3,567
-46% -$21.1K
NBSE
3702
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$25K ﹤0.01%
265
-181
-41% -$20K
NMTR
3703
DELISTED
9 Meters Biopharma
NMTR
$25K ﹤0.01%
1,121
+788
+237% +$19.3K
TTCF
3704
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$25K ﹤0.01%
1,145
-1,786
-61% -$35K
RXDX
3705
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$25K ﹤0.01%
+999
New +$22.3K
SVFA
3706
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$25K ﹤0.01%
2,484
+2,084
+521% +$20.9K
NH
3707
DELISTED
NantHealth, Inc
NH
$25K ﹤0.01%
717
+107
+18% +$4.25K
AKUS
3708
DELISTED
Akouos Inc
AKUS
$25K ﹤0.01%
1,977
-3,343
-63% -$45.3K
ATRS
3709
DELISTED
Antares Pharma, Inc.
ATRS
$25K ﹤0.01%
5,723
-12,982
-69% -$52.9K
TLMD
3710
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$25K ﹤0.01%
4,322
+3,289
+318% +$21.9K
PPD
3711
DELISTED
PPD, Inc. Common Stock
PPD
$25K ﹤0.01%
524
+322
+159% +$14.5K
INBX
3712
DELISTED
Inhibrx, Inc. Common Stock
INBX
$25K ﹤0.01%
893
-295
-25% -$6.14K
ALX
3713
Alexander's
ALX
$1.39B
$24K ﹤0.01%
90
-154
-63% -$42.6K
AMPY icon
3714
Amplify Energy
AMPY
$186M
$24K ﹤0.01%
+5,845
New +$19.4K
BDTX icon
3715
Black Diamond Therapeutics
BDTX
$120M
$24K ﹤0.01%
1,947
+463
+31% +$9.15K
CIO
3716
DELISTED
City Office REIT
CIO
$24K ﹤0.01%
1,891
-3,345
-64% -$38.7K
CNTA
3717
DELISTED
Centessa Pharmaceuticals
CNTA
$24K ﹤0.01%
+1,077
New +$25.3K
CSV icon
3718
Carriage Services
CSV
$534M
$24K ﹤0.01%
651
-5,717
-90% -$213K
DRRX
3719
DELISTED
DURECT Corp
DRRX
$24K ﹤0.01%
1,489
-2,814
-65% -$49.1K
FTHM icon
3720
Fathom Holdings
FTHM
$23.5M
$24K ﹤0.01%
726
-620
-46% -$20.4K
GAN
3721
DELISTED
GAN Ltd
GAN
$24K ﹤0.01%
1,459
-436
-23% -$7.69K
GBR icon
3722
New Concept Energy
GBR
$3.67M
$24K ﹤0.01%
3,913
+3,669
+1,504% +$17.3K
GDEN
3723
DELISTED
Golden Entertainment
GDEN
$24K ﹤0.01%
531
-969
-65% -$37K
KOP icon
3724
Koppers
KOP
$870M
$24K ﹤0.01%
735
-5,673
-89% -$191K
LVO icon
3725
LiveOne
LVO
$62.8M
$24K ﹤0.01%
506
-463
-48% -$20.1K
147 148
149
150 151

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.